Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection

被引:275
作者
van Leeuwen, EMM
Remmerswaal, EBM
Vossen, MTM
Rowshani, AT
Wertheim-van Dillen, PME
van Lier, RAW
ten Berge, IJM
机构
[1] Acad Med Ctr, Expt Immunol Lab, NL-1105 AZ Amsterdam, Netherlands
[2] Emma Childrens Hosp, Dept Internal Med, Amsterdam, Netherlands
[3] Emma Childrens Hosp, Div Nephrol & Clin Immunol, Amsterdam, Netherlands
[4] Emma Childrens Hosp, Div Rheumatol, Amsterdam, Netherlands
[5] Acad Med Ctr, Dept Virol, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.4049/jimmunol.173.3.1834
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytotoxic CD4(+)CD28(-) T cells form a rare subset in human peripheral blood. The presence of CD4(+)CD28(-) cells has been associated with chronic viral infections, but how these particular cells are generated is unknown. In this study, we show that in primary CMV infections, CD4(+)CD28(-) T cells emerge just after cessation of the viral load, indicating that infection with CMV triggers the formation of CD4(+)CD28(-) T cells. In line with this, we found these cells only in CMV-infected persons. CD4(+)CD28(-) cells had an Ag-primed phenotype and expressed the cytolytic molecules granzyme B and perforin. Importantly, CD4(+)CD28(-) cells were to a large extent CMV-specific because proliferation was only induced by CMV-Ag, but not by recall Ags such as purified protein derivative or tetanus toxoid. CD4(+)CD28(-) cells only produced IFN-gamma after stimulation with CMV-Ag, whereas CD4(+)CD28(+) cells also produced IFN-gamma in response to varicella-zoster virus and purified protein derivative. Thus, CD4(+)CD28(-) T cells emerge as a consequence of CMV infection.
引用
收藏
页码:1834 / 1841
页数:8
相关论文
共 54 条
[1]  
ADAM E, 1987, LANCET, V2, P291
[2]   Characterization of the CD4+T cell response Epstein-Barr virus during primary and persistent infection [J].
Amyes, E ;
Hatton, C ;
Montamat-Sicotte, D ;
Gudgeon, N ;
Rickinson, AB ;
McMichael, AJ ;
Callan, MFC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (06) :903-911
[3]   Characterization of CD4+ CTLs ex vivo [J].
Appay, V ;
Zaunders, JJ ;
Papagno, L ;
Sutton, J ;
Jaramillo, A ;
Waters, A ;
Easterbrook, P ;
Grey, P ;
Smith, D ;
McMichael, AJ ;
Cooper, DA ;
Rowland-Jones, SL ;
Kelleher, AD .
JOURNAL OF IMMUNOLOGY, 2002, 168 (11) :5954-5958
[4]   A highly sensitive assay for detection and quantitation of human cytomegalovirus DNA in serum and plasma by PCR and electrochemiluminescence [J].
Boom, R ;
Sol, C ;
Gerrits, Y ;
De Boer, M ;
Wertheim-van Dillen, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) :1489-1497
[5]   Costimulation of human CD28- T cells by 4-1BB ligand [J].
Bukczynski, J ;
Wen, T ;
Watts, TH .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (02) :446-454
[6]   Infections and solid organ transplant rejection: a cause-and-effect relationship? [J].
Cainelli, F ;
Vento, S .
LANCET INFECTIOUS DISEASES, 2002, 2 (09) :539-549
[7]   Investigation of CMV disease in immunocompromised patients [J].
Emery, VC .
JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (02) :84-88
[8]   Expansion of the CD57 subset of CD8 T cells in HIV-1 infection is related to CMV serostatus [J].
Evans, TG ;
Kallas, EG ;
Luque, AE ;
Menegus, M ;
MçNair, C ;
Looney, RJ .
AIDS, 1999, 13 (09) :1139-1141
[9]   CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells [J].
Fontenot, AP ;
Gharavi, L ;
Bennett, SR ;
Canavera, SJ ;
Newman, LS ;
Kotzin, BL .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (05) :776-784
[10]   Primary immune responses to human CMV: a critical role for IFN-γ-producing CD4+ T cells in protection against CMV disease [J].
Gamadia, LE ;
Remmerswaal, EBM ;
Weel, JF ;
Bemelman, F ;
van Lier, RAW ;
Ten Berge, IJM .
BLOOD, 2003, 101 (07) :2686-2692